Xu Stella

DirectorDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Mar 22, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11.3M
Net Open-Market Flow
-$11.3M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 22, 2022Sell(S)1K$18.63$27K4.1M
Mar 21, 2022Sell(S)24K$19.01$456K4.1M
Mar 18, 2022Sell(S)13K$20.34$268K4.2M
Mar 18, 2022Sell(S)552K$19.04$10.5M4.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-020637) within minutes of acceptance. Every field above traces to the original document. Verify it directly: